ducovest

3020-OL:HK:HK-X DBMSCIUSA (HKD)

COMMON STOCK | Other |

Last Closing

USD 1351

Change

0.00 (0.00)%

Market Cap

N/A

Volume

165.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

There is no Profile data available for 3020-OL.HK.

Currency: HKD

Country : Hong Kong

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-05 )

Largest Industry Peers for Other

Symbol Name Price(Change) Market Cap
1863:HK China Longevity Group Company ..

N/A

 USD 1.17B
8355:HK I-CONTROL

N/A

 USD 0.39B
8343:HK HongGuang Lighting Holdings Co..

+0.03 (+4.84%)

 USD 0.31B
0648:HK CHINA RENJ

N/A

 USD 0.12B
0287-OL:HK WINFAIR INV

N/A

 N/A
0362-OL:HK C ZENITH CHEM

N/A

 N/A
0406-OL:HK YAU LEE HOLD

-0.04 (-4.17%)

 N/A
0294-OL:HK YANGTZEKIANG

+0.04 (+3.51%)

 N/A
0419-OL:HK JIUHAO HEALTH

N/A

 N/A
0332-OL:HK YUANHENG GAS

N/A

 N/A

ETFs Containing 3020-OL:HK

DXZ:CA Dynamic Active U.S. Mid-C.. 11.35 % 0.87 %

-0.12 (1.29%)

 CAD 0.04B
IHF iShares U.S. Healthcare P.. 10.50 % 0.43 %

+0.44 (+1.29%)

 N/A
TETF 6.19 % 0.64 %

N/A

 N/A
BGU:CA Bristol Gate Concentrated.. 5.48 % 0.85 %

-0.20 (1.29%)

 CAD 0.13B
FHI:CA CI Health Care Giants Cov.. 5.10 % 0.75 %

+0.03 (+1.29%)

 CAD 0.10B
UTRN Vesper U.S. Large Cap Sho.. 4.10 % 0.00 %

+0.24 (+1.29%)

 USD 0.02B
IAI iShares U.S. Broker-Deale.. 3.84 % 0.42 %

+2.22 (+1.29%)

 N/A
CBUF:XETRA iShares MSCI World Health.. 2.93 % 0.00 %

-0.12 (1.29%)

 N/A
HDIV 2.83 % 0.00 %

N/A

 N/A
RYH 1.72 % 0.40 %

N/A

 N/A
DSTL Distillate US Fundamental.. 1.72 % 0.00 %

+0.67 (+1.29%)

 USD 2.09B
HONR 1.20 % 0.65 %

N/A

 N/A
SMD 0.45 % 0.10 %

N/A

 N/A
ESGL ESGL Holdings Limited Ord.. 0.00 % 0.40 %

+0.08 (+1.29%)

 USD 0.04B
JKH iShares Morningstar Mid-C.. 0.00 % 0.30 %

N/A

 N/A
RYF 0.00 % 0.40 %

N/A

 N/A
VVL:CA Vanguard Global Value Fac.. 0.00 % 0.40 %

+0.29 (+1.29%)

 N/A
WBIF WBI BullBear Value 3000 E.. 0.00 % 1.05 %

+0.32 (+1.29%)

 N/A
XXM:CA 0.00 % 0.68 %

N/A

 N/A
FSWD:LSE iShares Edge MSCI World M.. 0.00 % 0.00 %

+0.88 (+1.29%)

 N/A
IFSW:LSE iShares Edge MSCI World M.. 0.00 % 0.00 %

+0.18 (+1.29%)

 N/A
IBCZ:F iShares IV Public Limited.. 0.00 % 0.00 %

-0.15 (1.29%)

 N/A
IS07:F iShares IV Public Limited.. 0.00 % 0.00 %

+0.02 (+1.29%)

 N/A
IS07:XETRA iShares Edge MSCI World M.. 0.00 % 0.00 %

+0.05 (+1.29%)

 N/A
IMCG iShares Morningstar Mid-C.. 0.00 % 0.00 %

+0.96 (+1.29%)

 N/A

Market Performance

  Market Performance vs. Industry/Classification (Other) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.59% 46% F 50% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.59% 46% F 49% F
Trailing 12 Months  
Capital Gain 15.92% 68% D+ 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 15.92% 64% D 65% D
Trailing 5 Years  
Capital Gain 86.47% 80% B- 90% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 86.47% 80% B- 87% B+
Average Annual (5 Year Horizon)  
Capital Gain 17.33% 78% C+ 76% C+
Dividend Return 17.33% 76% C+ 75% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 20.15% 75% C 73% C
Risk Adjusted Return 85.98% 98% N/A 97% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (HKD)

Quarterly Financials (HKD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike